Amgen pledges $1.5bn for CytomX preclinical cancer drugs PM Live By John Harbison|2017-10-04T12:43:05-08:00October 4, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Amgen pledges $1.5bn for CytomX preclinical cancer drugs Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
